The Swiss drugmaker on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash
The Swiss drugmaker on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash
The Harvard-trained doctor and former McKinsey alumnus will succeed outgoing CEOÂ Jimenez in February 2018.
The American Bazaar is a publication of American Bazaar, Inc., based in Germantown, MD.
